A Study of SDI-118 in Participants in Remission From Depression

NCT05212116 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Development Plan Amended

Conditions

Depression in Remission

Interventions

DRUG: SDI-118
DRUG: Placebo

Sponsor

Syndesi Therapeutics

Collaborators

[object Object]